BIOLINQ Trademark

Trademark Overview

On Sunday, May 30, 2021, a trademark application was filed for BIOLINQ with the United States Patent and Trademark Office. The USPTO has given the BIOLINQ trademark a serial number of 90743811. The federal status of this trademark filing is REGISTERED as of Tuesday, November 28, 2023. This trademark is owned by Biolinq, Inc.. The BIOLINQ trademark is filed in the Medical Instrument Products category with the following description:

Wearable monitors used to measure biometric data for medical use; glucose meters; wearable devices, namely, continuous glucose sensors for monitoring blood glucose levels for medical purposes
biolinq

General Information

Serial Number90743811
Word MarkBIOLINQ
Filing DateSunday, May 30, 2021
Status700 - REGISTERED
Status DateTuesday, November 28, 2023
Registration Number7231354
Registration DateTuesday, November 28, 2023
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 22, 2022

Trademark Statements

Description of MarkThe mark consists of the word biolinq with a continuous path that forms a cross.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesWearable monitors used to measure biometric data for medical use; glucose meters; wearable devices, namely, continuous glucose sensors for monitoring blood glucose levels for medical purposes

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, August 24, 2021
Primary Code010
First Use Anywhere DateWednesday, July 6, 2022
First Use In Commerce DateWednesday, July 6, 2022

Trademark Owner History

Party NameBiolinq Incorporated
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameBiolinq Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameBiolinq, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Wednesday, June 2, 2021NEW APPLICATION ENTERED
Tuesday, August 24, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 15, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 25, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, November 15, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 15, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, February 12, 2022ASSIGNED TO EXAMINER
Monday, February 28, 2022NON-FINAL ACTION WRITTEN
Monday, February 28, 2022NON-FINAL ACTION E-MAILED
Monday, February 28, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 23, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 23, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 24, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 19, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 2, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 22, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 22, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, December 22, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, December 22, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 22, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 22, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, January 17, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 18, 2023ASSIGNED TO PETITION STAFF
Monday, January 23, 2023POST PUBLICATION AMENDMENT - ENTERED
Wednesday, February 1, 2023TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, March 13, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 14, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, May 1, 2023TEAS STATEMENT OF USE RECEIVED
Monday, May 1, 2023USE AMENDMENT FILED
Wednesday, September 13, 2023STATEMENT OF USE PROCESSING COMPLETE
Saturday, October 21, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, October 24, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, April 23, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 23, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 23, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 28, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 28, 2023REGISTERED-PRINCIPAL REGISTER

Related Keywords

biolinq glucose medical wearable continuous sensors monitoring purposes levels blood namely